José Ortiz

Race and Ethnicity and Overall Survival in Pediatric Acute Myeloid Leukemia

Daniel J. Zheng, Long Khuong, Catherine Aftandilian, Kira O'Neil Bona et autres

Importance: Hispanic and non-Hispanic Black (hereafter, Black) children with acute myeloid leukemia (AML) have historically experienced worse survival outcomes compared with non-Hispanic White (hereafter, White) children. Understanding specific intermediate pathways underlying these outcome disparities is a critical step to directing interventional efforts …

us (code pays fourni par la source)

Real-world post-relapse survival outcomes in children with Acute Myeloid Leukemia by race and ethnicity

Daniel Jia Zheng, Quynh Long Khuong, Catherine C. Aftandilian, Kira O'Neil Bona et autres

Abstract Introduction: Non-Hispanic Black (NHB) and Hispanic children with acute myeloid leukemia (AML) have historically had worse overall survival (OS) compared to their non-Hispanic White (NHW) peers. While our prior work demonstrated comparable risk of relapse by race/ethnicity, it remains unknown whether …

us (code pays fourni par la source)

National Trends in Dexrazoxane and Cardiovascular Health Care Utilization for Children With Acute Myeloid Leukemia

Daniel Jia Zheng, Gary Hettinger, Jonathan D. Bender, Alexis C. Boulter et autres

This cohort study examines trends in dexrazoxane and cardiovascular health care use for children with acute myeloid leukemia (AML) in the US.

us (code pays fourni par la source)

Real-world generalizability of clinical trial cytomolecular risk in pediatric acute myeloid leukemia: a report from the REAL-AML cohort

Daniel Jia Zheng, Gary Hettinger, Catherine C. Aftandilian, Kira O'Neil Bona et autres

Cytomolecular features critical for risk-stratified treatment determination in pediatric acute myeloid leukemia (AML) were expanded in Children's Oncology Group (COG) Phase III trial AAML1831 based on previous trials. It remains unknown whether the cytomolecular risk profiles are generalizable to the real-world. We …

us (code pays fourni par la source)

Gemcitabine and Oxaliplatin‐Induced Veno‐Occlusive Disease in a Pediatric Patient With Multiply Relapsed Germ Cell Tumor

José Ortiz, Alix Eden Seif, Lisa J. States, Sanjiv D. Mehta et autres

Data sharing is not applicable to this article as no new data were created or analyzed in this study.

us (code pays fourni par la source)

LB1227 Synergizing ASOs unveil MAPK pathway associated vulnerabilities in drug resistant melanoma

Valentin Feichtenschlager, Dasha Hohlova, Ciara Callanan, José Ortiz et autres

Near Universal National Uptake of Dexrazoxane in the Real-World Setting Associated with Reduced Cardiac ICU Care Requirements in Pediatric Acute Myeloid Leukemia

Daniel Jia Zheng, Gary Hettinger, Lusha Cao, Caitlin W. Elgarten et autres

Background: Cardiotoxicity is one of the most significant toxicities associated with pediatric acute myeloid leukemia (AML) treatment due to the high cumulative anthracycline doses required in the standard chemotherapy backbone. Dexrazoxane has proven to be an effective cardioprotectant to mitigate this toxicity, …

us (code pays fourni par la source)

Outcomes of patients with newly diagnosed light chain amyloidosis according to eligibility for clinical trials: Experience of a single institution PA131 (#468)

Natalia Tovar, Carles Tolosa, Luís Gerardo, Carlos Galindo Fernández et autres

Deconstructing the role of MALAT1 in MAPK-signaling in melanoma: insights from antisense oligonucleotide treatment

Valentin Feichtenschlager, Yixuan James Zheng, Wilson Wai-Shing Ho, Li-Nan Chen et autres

// Valentin Feichtenschlager 1 , 2 , Yixuan James Zheng 1 , 3 , Wilson Ho 1 , Linan Chen 1 , Ciara Callanan 1 , Christopher Chen 1 , Albert Lee 1 , Jose Ortiz 1 , Klemens Rappersberger 2 and …

us (code pays fourni par la source)

In-Stent Restenosis in Saphenous Vein Grafts (from the DIVA Trial)

Iosif Xenogiannis, Bavana V. Rangan, Lauren Uyeda, Subhash Banerjee et autres

us, hu (code pays fourni par la source)

Impact of Docetaxel conjugated Nanodiamonds on Gene expression of Prostate Cancer (PC3) Cells

José Ortiz, Sameer Joshi, Sandeep Singh, Komal Vig

Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial

Emmanouil S. Brilakis, Robert Edson, Deepak L. Bhatt, Steven Louis Goldman et autres

us (code pays fourni par la source)